Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Mol Genet Genomic Med ; 10(10): e2023, 2022 10.
Artículo en Inglés | MEDLINE | ID: mdl-35985662

RESUMEN

Corneal dystrophies describe a clinically and genetically heterogeneous group of inherited disorders. The International Classification of Corneal Dystrophies (IC3D) lists 22 types of corneal dystrophy, 17 of which have been demonstrated to result from pathogenic variants in 19 identified genes. In this study, we investigated the diagnostic yield of genetic testing in a well-characterised cohort of 58 individuals from 44 families with different types of corneal dystrophy. Individuals diagnosed solely with Fuchs endothelial corneal dystrophy were excluded. Clinical details were obtained from the treating ophthalmologist. Participants and their family members were tested using a gene candidate and exome sequencing approach. We identified a likely molecular diagnosis in 70.5% families (31/44). The detection rate was significantly higher among probands with a family history of corneal dystrophy (15/16, 93.8%) than those without (16/28, 57.1%, p = .015), and among those who had undergone corneal graft surgery (9/9, 100.0%) compared to those who had not (22/35, 62.9%, p = .041). We identified eight novel variants in five genes and identified five families with syndromes associated with corneal dystrophies. Our findings highlight the genetic heterogeneity of corneal dystrophies and the clinical utility of genetic testing in reaching an accurate clinical diagnosis.


Asunto(s)
Distrofias Hereditarias de la Córnea , Australia , Estudios de Cohortes , Distrofias Hereditarias de la Córnea/diagnóstico , Distrofias Hereditarias de la Córnea/genética , Distrofias Hereditarias de la Córnea/patología , Pruebas Genéticas , Humanos
2.
J Cataract Refract Surg ; 48(6): 716, 2022 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-35703842
3.
Ophthalmology ; 128(7): 993-1004, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33245936

RESUMEN

PURPOSE: To investigate corneal stiffness parameters (SPs) as predictors of future progression risk in glaucoma suspect eyes. DESIGN: Prospective, longitudinal study. PARTICIPANTS: Three hundred seventy-one eyes from 228 primary open-angle glaucoma suspects, based on optic disc appearance, with normal baseline Humphrey Visual Field (HVF; Carl Zeiss Meditec) results. METHODS: Baseline corneal SPs were measured using Corvis ST (Oculus Optikgeräte GmbH). Participants were followed up every 6 months with clinical examination, HVF testing, and OCT. The baseline SP at first applanation (SP-A1) and highest concavity predicted the prospective outcome measures. MAIN OUTCOME MEASURES: Structural progression was measured by the OCT rate of thinning of the retinal nerve fiber layer (RNFL) and ganglion cell-inner plexiform layer (GCIPL). Functional progression was assessed by permutation analysis of pointwise linear regression criteria on HVF testing. RESULTS: Stiffness parameters correlated positively with central corneal thickness (CCT), which was adjusted for in all analyses. A higher SP-A1, suggestive of a stiffer cornea, was associated with a faster rate of RNFL thinning (P < 0.001), synergistic with thinner CCT (P = 0.004) over a mean follow-up of 4.2 years. Eyes with higher SP-A1 and thinner CCT (thin and stiff corneas) showed accelerated RNFL thinning by 0.72 µm/year relative to eyes with lower SP-A1 and thicker CCT (95% confidence interval [CI], 0.17-1.28; P = 0.011) and were at 2.9-fold higher likelihood of fast RNFL progression of more than 1 µm/year (95% CI, 1.4-6.1; P = 0.006). Consistent results also were observed with GCIPL thinning. Furthermore, a higher SP-A1 was associated with a greater risk of visual field progression (P = 0.002), synergistic with thinner CCT (P = 0.010). Eyes with higher SP-A1 and thinner CCT were at 3.7-fold greater risk of visual field progression relative to eyes with thicker CCT and lower SP-A1 (95% CI, 1.3-10.5; P = 0.014). CONCLUSIONS: Glaucoma suspect eyes with higher corneal SPs and lower CCT, suggestive of thin and stiff corneas, are at greater risk of progression. Corneal SPs seem to act synergistically with CCT as risk factors for glaucoma progression.


Asunto(s)
Córnea/fisiopatología , Glaucoma de Ángulo Abierto/fisiopatología , Presión Intraocular/fisiología , Tomografía de Coherencia Óptica/métodos , Córnea/diagnóstico por imagen , Progresión de la Enfermedad , Elasticidad , Femenino , Estudios de Seguimiento , Glaucoma de Ángulo Abierto/diagnóstico , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Campos Visuales/fisiología
4.
Ophthalmology ; 127(6): 758-766, 2020 06.
Artículo en Inglés | MEDLINE | ID: mdl-32085876

RESUMEN

PURPOSE: Developmental abnormalities of the ocular anterior segment in some cases can lead to ocular hypertension and glaucoma. CPAMD8 is a gene of unknown function recently associated with ocular anterior segment dysgenesis, myopia, and ectopia lentis. We sought to assess the contribution of biallelic CPAMD8 variants to childhood and juvenile open-angle glaucoma. DESIGN: Retrospective, multicenter case series. PARTICIPANTS: A total of 268 probands and their relatives with a diagnosis of childhood or juvenile open-angle glaucoma. PURPOSE: Developmental abnormalities of the ocular anterior segment in some cases can lead to ocular hypertension and glaucoma. CPAMD8 is a gene of unknown function recently associated with ocular anterior segment dysgenesis, myopia, and ectopia lentis. We sought to assess the contribution of biallelic CPAMD8 variants to childhood and juvenile open-angle glaucoma. METHODS: Patients underwent a comprehensive ophthalmic assessment, with DNA from patients and their relatives subjected to genome, exome, or capillary sequencing. CPAMD8 RNA expression analysis was performed on tissues dissected from cadaveric human eyes. MAIN OUTCOME MEASURES: Diagnostic yield within a cohort of childhood and juvenile open-angle glaucoma, prevalence and risk of ophthalmic phenotypes, and relative expression of CPAMD8 in the human eye. RESULTS: We identified rare (allele frequency < 4×10-5) biallelic CPAMD8 variants in 5.7% (5/88) of probands with childhood glaucoma and 2.1% (2/96) of probands with juvenile open-angle glaucoma. When including family members, we identified 11 individuals with biallelic variants in CPAMD8 from 7 unrelated families. Nine of these individuals were diagnosed with glaucoma (9/11, 81.8%), with a mean age at diagnosis of 9.22±14.89 years, and all individuals with glaucoma required 1 or more incisional procedures to control high intraocular pressure. Iris abnormalities were observed in 9 of 11 individuals, cataract was observed in 8 of 11 individuals (72.7%), and retinal detachment was observed in 3 of 11 individuals (27.3%). CPAMD8 expression was highest in neural crest-derived tissues of the adult anterior segment, suggesting that CPAMD8 variation may cause malformation or obstruction of key drainage structures. CONCLUSIONS: Biallelic CPAMD8 variation was associated with a highly heterogeneous phenotype and in our cohorts was the second most common inherited cause of childhood glaucoma after CYP1B1 and juvenile open-angle glaucoma after MYOC. CPAMD8 sequencing should be considered in the investigation of both childhood and juvenile open-angle glaucoma, particularly when associated with iris abnormalities, cataract, or retinal detachment.


Asunto(s)
Segmento Anterior del Ojo/anomalías , Complemento C3/genética , Anomalías del Ojo/genética , Glaucoma de Ángulo Abierto/genética , Polimorfismo de Nucleótido Simple , Inhibidor de Tripsina Pancreática de Kazal/genética , alfa-Macroglobulinas/genética , Adolescente , Adulto , Niño , Preescolar , Exoma/genética , Femenino , Frecuencia de los Genes , Humanos , Hidroftalmía/genética , Lactante , Recién Nacido , Masculino , Linaje , Fenotipo , ARN/genética , Estudios Retrospectivos , Análisis de Secuencia de ADN , Adulto Joven
5.
JAMA Ophthalmol ; 137(4): 348-355, 2019 04 01.
Artículo en Inglés | MEDLINE | ID: mdl-30653210

RESUMEN

Importance: Both primary and secondary forms of childhood glaucoma have many distinct causative mechanisms, and in many cases a cause is not immediately clear. The broad phenotypic spectrum of secondary glaucoma, particularly in individuals with variants in FOXC1 or PITX2 genes associated with Axenfeld-Rieger syndrome, makes it more difficult to diagnose patients with milder phenotypes. These cases are occasionally classified and managed as primary congenital glaucoma. Objective: To investigate the prevalence of FOXC1 variants in participants with a suspected diagnosis of primary congenital glaucoma. Design, Setting, and Participants: Australian and Italian cohorts were recruited from January 1, 2007, through March 1, 2016. Australian individuals were recruited through the Australian and New Zealand Registry of Advanced Glaucoma and Italian individuals through the Genetic and Ophthalmology Unit of l'Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda in Milan, Italy. We performed exome sequencing, in combination with Sanger sequencing and multiplex ligation-dependent probe amplification, to detect variants of FOXC1 in individuals with a suspected diagnosis of primary congenital glaucoma established by their treating specialist. Data analysis was completed from June 2015 to November 2017. Main Outcome and Measures: Identification of single-nucleotide and copy number variants in FOXC1, along with phenotypic characterization of the individuals who carried them. Results: A total of 131 individuals with a suspected diagnosis of primary congenital glaucoma were included. The mean (SD) age at recruitment in the Australian cohort was 24.3 (18.1) years; 37 of 84 Australian participants (44.0%) were female, and 71 of 84 (84.5%) were of European ancestry. The mean (SD) age at recruitment was 22.5 (18.4) years in the Italian cohort; 21 of 47 Italian participants (44.7%) were female, and 45 of 47 (95.7%) were of European ancestry. We observed rare, predicted deleterious FOXC1 variants in 8 of 131 participants (6.1%), or 8 of 166 participants (4.8%) when including those explained by variants in CYP1B1. On reexamination or reinvestigation, all of these individuals had at least 1 detectable ocular and/or systemic feature associated with Axenfeld-Rieger syndrome. Conclusions and Relevance: These data highlight the genetic and phenotypic heterogeneity of childhood glaucoma and support the use of gene panels incorporating FOXC1 as a diagnostic aid, especially because clinical features of Axenfeld-Rieger syndrome can be subtle. Further replication of these results will be needed to support the future use of such panels.


Asunto(s)
Factores de Transcripción Forkhead/genética , Glaucoma/epidemiología , Glaucoma/genética , Adolescente , Adulto , Australia/epidemiología , Niño , Femenino , Glaucoma/congénito , Humanos , Masculino , Nueva Zelanda/epidemiología , Prevalencia , Adulto Joven
6.
PLoS One ; 13(12): e0206684, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30517101

RESUMEN

PURPOSE: The ganglion cell analysis (GCA) of the CIRRUSTM HD-OCT (Carl Zeiss, Meditec; Dublin, CA) provides measurement of the macular ganglion cell-inner plexiform layer (GCIPL) thickness. This study determined the frequency of scan artefacts and errors in GCIPL imaging in individuals undergoing HD-OCT surveillance for glaucoma. METHOD: A total of 1439 eyes from 721 subjects enrolled in a prospective study assessing predictors of glaucoma progression underwent macular GCIPL imaging with the CIRRUS HD-OCT at recruitment. The prevalence of acquisition errors, segmentation errors, and co-morbid macular pathology was determined. RESULTS: A total of 87 (6.0%) of the 1439 scans had either acquisition errors, segmentation artefacts, or other macular pathology. The most common co-morbid macular pathology was epiretinal membrane in 2.2% of eyes. CONCLUSION: The macular GCIPL scan was artefact free in 94% of eyes. However, epiretinal membrane and high myopia can cause scan artefact and should be considered when interpreting the results.


Asunto(s)
Errores Diagnósticos , Glaucoma/diagnóstico por imagen , Células Ganglionares de la Retina/patología , Tomografía de Coherencia Óptica , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia
8.
Clin Exp Ophthalmol ; 37(9): 836-41; quiz 903-4, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-20092591

RESUMEN

PURPOSE: To determine the sensitivity of manufacturer supported normative algorithms in Heidelberg retinal tomography (HRT) and Stratus optical coherence tomography (OCT) in detecting advanced primary open angle glaucoma. METHODS: A total of 157 subjects with advanced primary open angle glaucoma were recruited. The eye with the more severe glaucoma, as judged by mean deviation on Humphrey visual field, was imaged. The total number of optic disc sectors classified as being outside normal limits on Moorfields Regression Analysis (MRA) from the HRT II and HRT 3 software or from the sector and quadrant averages analysis of the Retinal Nerve Fiber Layer OCT scans was compared using the Wilcoxon signed ranks test. RESULTS: At least one segment in each eye was identified as being outside normal limits by the OCT sector Retinal Nerve Fiber Layer analysis (100% sensitivity). Five eyes were classified as being within normal limits on the OCT quadrant average analysis (96.8% sensitivity). Four eyes were found to be either completely within normal limits or borderline on the HRT II MRA (97.5% sensitivity), of which one was subsequently identified as being outside normal limits by the HRT 3 MRA. The total number of segments classified as being outside normal limits was greater on HRT 3 MRA than HRT II MRA (P < 0.001). CONCLUSION: Automated optic nerve imaging devices rarely produce a totally normal result in the presence of advanced primary open angle glaucoma. The Stratus OCT Retinal Nerve Fiber Layer clock hour normative database performs better than other modalities studied. These findings are important in considering the utility of these algorithms for community screening.


Asunto(s)
Glaucoma de Ángulo Abierto/diagnóstico , Rayos Láser , Oftalmoscopía , Tomografía de Coherencia Óptica , Anciano , Anciano de 80 o más Años , Algoritmos , Técnicas de Diagnóstico Oftalmológico/instrumentación , Progresión de la Enfermedad , Femenino , Glaucoma de Ángulo Abierto/complicaciones , Humanos , Masculino , Tamizaje Masivo , Disco Óptico/patología , Enfermedades del Nervio Óptico/diagnóstico , Enfermedades del Nervio Óptico/etiología , Sensibilidad y Especificidad , Campos Visuales
11.
Clin Exp Ophthalmol ; 35(9): 863-5, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18173418

RESUMEN

Idiopathic intracranial hypertension can cause severe optic nerve damage with irreversible visual loss. Heidelberg retina tomography is a sensitive and reproducible tool that can be used in the monitoring of optic disc swelling due to IIH. We demonstrate that the three-dimensional images produced are easy to interpret, indicate progression or resolution and improve the timing of intervention in multidisciplinary settings by facilitating communication between specialists.


Asunto(s)
Hipertensión Intracraneal/complicaciones , Microscopía Confocal , Oftalmoscopía , Papiledema/diagnóstico , Papiledema/etiología , Adulto , Progresión de la Enfermedad , Femenino , Humanos , Imagenología Tridimensional , Hipertensión Intracraneal/cirugía
12.
Clin Exp Ophthalmol ; 35(9): 865-7, 2007 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18173419

RESUMEN

The most effective dose of mitomycin C (MMC) in the treatment of primary acquired melanosis (PAM) with atypia of the conjunctiva and cornea has yet to be established. This case report describes successful treatment of PAM with atypia with a single four day cycle of 0.02% MMC.


Asunto(s)
Alquilantes/uso terapéutico , Enfermedades de la Conjuntiva/tratamiento farmacológico , Enfermedades de la Conjuntiva/patología , Melanosis/tratamiento farmacológico , Melanosis/patología , Mitomicina/uso terapéutico , Anciano , Alquilantes/administración & dosificación , Conjuntiva/patología , Córnea/patología , Esquema de Medicación , Femenino , Humanos , Mitomicina/administración & dosificación
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...